Journal Information
Vol. 99. Issue 9.
Pages 727-730 (November 2008)
Share
Share
Download PDF
More article options
Vol. 99. Issue 9.
Pages 727-730 (November 2008)
Case reports
Full text access
Two Cases of Eruptive Pyoderma Gangrenosum Associated with Cocaine Use
Piodermas Gangrenosos Eruptivos Asociados al Consumo de Cocaína Inhalada. Presentación de dos Casos
Visits
6019
E. Roche
Corresponding author
erochega@yahoo.es

Correspondence: Hospital General Universitario de Valencia, Servicio de Dermatología, Avda. Tres Cruces s/n, 46014 Valencia, Spain.
, T. Martínez-Menchón, J.L. Sánchez-Carazo, V. Oliver, V. Alegre de Miquel
Departamento de Dermatología, Hospital General Universitario de Valencia, Valencia, Spain
This item has received
Article information
Abstract

We present the cases of 2 regular cocaine users aged 30 and 37 years who developed a cutaneous condition with an identical presentation and a similar clinical course. The lesions first appeared as eruptions on the back and then spread to other parts of the body. They consisted of painful inflammatory nodules that developed into abscesses and ulcers that grew outwards. They had a granulomatous base and irregular violaceous edges. The results of histopathologic studies were compatible with the clinical diagnosis of pyoderma gangrenosum, and additional tests ruled out underlying diseases. After several therapeutic failures with usual treatments, the patients responded quickly to infliximab after interrupting their cocaine consumption. The association between pyoderma gangrenosum and cocaine use was clear as both suffered clinical relapses at the same time as they started using the drug again.

Key words:
pyoderma gangrenosum
cocaine
infliximab
Resumen

Presentamos los casos de dos pacientes varones, de 30 y 37 años, consumidores habituales de cocaína inhalada, que desarrollaron un cuadro cutáneo de idéntica presentación y evolución clínica. Las lesiones se iniciaban de forma eruptiva en la espalda y posteriormente se generalizaban. Consistían en nódulos inflamatorios y dolorosos, que evolucionaban hasta abscesos y úlceras de crecimiento centrífugo, fondo granulomatoso y bordes violáceos e irregulares. Los estudios histopatológicos fueron compatibles con los diagnósticos clínicos de piodermas gangrenosos (PG) y las exploraciones complementarias realizadas descartaron patologías subyacentes. Tras varios fracasos terapéuticos con terapias clásicas, respondieron rápidamente a infliximab asociado a deshabituación de cocaína. La asociación de PG con el consumo de cocaína quedó patente, ya que ambos mostraron recidivas clínicas simultáneamente con recaídas en su adicción.

Palabras clave:
pioderma gangrenoso
cocaína
infliximab
Full text is only aviable in PDF
References
[1.]
S. Ahmadi, F.C. Powell.
Pyoderma gangrenosum: uncommon presentations.
Clin Dermatol, 23 (2005), pp. 612-620
[2.]
A. Srebrnik, E. Shachar, S. Brenner.
Suspected induction of a pyoderma gangrenosum-like eruption due to sulpiride treatment.
Cutis, 67 (2001), pp. 253-256
[3.]
M.C.Y. Heng, G. Haberfeld.
Thrombotic phenomena associated with intravenous cocaine.
J Am Acad Dermatol, 16 (1987), pp. 462-468
[4.]
P. Del Giudice.
Cutaneous complications of intravenous drug abuse.
Br J Dermatol, 150 (2004), pp. 1-10
[5.]
D.J. Trozak, W.M. Gould.
Cocaine abuse and connective tissue disease.
J Am Acad Dermatol, 10 (1984), pp. 525
[6.]
G.F. Hofbauer, J. Hafner, R.M. Trueb.
Urticarial vasculitis following cocaine use.
Br J Dermatol, (1999), pp. 600-601
[7.]
T. Jouary, G. Bens, S. Lepreux, C. Buzenet, A. Taieb.
Livedo nécrotique localise après injection de cocaïne.
Ann Dermatol Venereol, 130 (2003), pp. 537-540
[8.]
A. Gutiérrez, J.D. England, W.C. Krupski.
Cocaine induced peripheral vascular occlusive disease, a case report.
Angiology, 49 (1998), pp. 221-224
[9.]
V.B. Mouraviev, S.E. Pautler, W.P. Hayman.
Fournier's gangrene following penile self-injection with cocaine.
Scand J Urol Nephrol, 36 (2002), pp. 317-318
[10.]
K.J. Tomecki, S.M. Wikas.
Cocaine-related bullous disease.
J Am Acad Dermatol, 12 (1985), pp. 585-586
[11.]
T. Matsumura, K.C. Sato-Matsumura, M. Ota, T. Yokota, K. Arita, D. Kodama, et al.
Two cases of pyoderma gangrenosum complicated with nasal septal perforation.
Br J Dermatol, 141 (1999), pp. 1133-1135
[12.]
J. Reichrath, G. Bens, A. Bonowitz, W. Tilgen.
Treatment recommendations for pyoderma gangrenosum: an evidencebased review of the literature based on more than 350 patients.
J Am Acad Dermatol, 53 (2005), pp. 273-283
[13.]
L. Jenne, B. Sauter, P. Thumann, M. Hertl, G. Schuler.
Successul treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab.
Br J Dermatol, 150 (2004), pp. 380-382
[14.]
M.R. Kaur, H.M. Lewis.
Severe recalcitrant pyoderma gangrenosum treated with infliximab.
Br J Dermatol, 153 (2005), pp. 689-691
[15.]
D. Mimouni, G.J. Anhalt, D.J. Kouba, H.C. Nousari.
Infliximab for peristomal pyoderma gangrenosum.
Br J Dermatol, 148 (2003), pp. 813-816
Copyright © 2008. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?